Since the mid-1990s the Kaiser Family Foundation has partnered with U.S.-based media companies on comprehensive HIV/AIDS campaigns. This paper, published in Health Affairs, Vol. 24, Issue 3, May/June 2005, outlines the unique public education model that it is using, and how Kaiser is expanding this work globally by working with some…
HIV/AIDSSee more about HIV/AIDS
- view as grid
- view as list
This report provides the first comprehensive look at the U.S. government agencies and programs involved in the nation’s global health response, including their funding and their approaches. The report also provides overviews of the large-scale global health initiatives of the U.S. government, information on which countries receive support from the U.S., and a review of the key laws governing U.S. global health policy and relevant Congressional committees.
Insurance Coverage and Access to HIV Testing and Treatment: Considerations for Individuals at Risk for Infection and for Those with Undiagnosed Infection
Of the estimated 1.2 million people living with HIV/AIDS in the United States, approximately 500,000 are not receiving care for their disease. This includes an estimated 250,000 people who do not know they are HIV positive. This article reviews data on insurance coverage and access to HIV testing and treatment,…
The Opening Session from the XVIII International AIDS Conference held in Vienna, Austria, July 18-23, 2010.
Highlights of Kaiser Family Foundation’s coverage of the XVIII International AIDS Conference. The conference was held July 18 – July 23, 2010, in Vienna Austria.
This Kaiser/CSIS forum examines the major policy, research and other developments arising from the 2010 International AIDS Conference (AIDS 2010) in Vienna, Austria.
This session will explore how policy makers and programme managers can work with the current state of knowledge and unanswered questions about what works in HIV prevention to develop strategic, combination prevention responses.
AIDS 2012: Comprehensive HIV Prevention for People Who Use Drugs: Ways Forward for Inclusion of Needle and Syringe Exchange Programmes
This session will address the potential impacts of restrictions on NSEPs, and propose ways forward for public health actors, community stakeholders, and drug users themselves to maintain and expand comprehensive services, including needle and syringe exchanges, despite the limitations in funding, restrictive political environments, and other barriers to the implementation of this preventive intervention.
This session will bring together some of these global leaders to discuss how, in their experience, public-private partnerships are an innovative way to bring together diverse organizations and target the same goal of efficient local programmes that, at the same time, translate into powerful advocacy tools at the global level.
This session will present examples of in-country ownership for developing strategies and solutions for achieving national HIV goals, drawing on the perspectives of government and business sectors.